|
Market Closed -
Nasdaq
04:00:00 30/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 26.68 USD | -2.59% |
|
+8.99% | -0.37% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 1.13B 1B 947M 858M 1.61B 109B 1.62B 11.34B 4.37B 55.62B 4.26B 4.17B 179B | P/E 2026 * |
12.3x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.44B 1.27B 1.2B 1.09B 2.04B 138B 2.06B 14.37B 5.54B 70.49B 5.4B 5.28B 226B | EV / Sales 2026 * |
1.92x | EV / Sales 2027 * | 1.68x |
| Free-Float |
47.23% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
Boerse Muenchen
| 29A | Real-time | |
Deutsche Boerse AG
| 29A | Delayed | |
Börse Stuttgart
| 29A | Delayed | |
Tradegate
| 29A | Real-time |
Last Transcript: Amphastar Pharmaceuticals, Inc.
| 1 day | -2.59% | ||
| 1 week | +8.99% | ||
| Current month | +18.42% | ||
| 1 month | +21.22% | ||
| 3 months | +22.50% | ||
| 6 months | +40.35% | ||
| Current year | -0.37% |
| 1 week | 24.2 | 27.8 | |
| 1 month | 21.52 | 27.8 | |
| Current year | 16.64 | 29.52 | |
| 1 year | 16.64 | 29.52 | |
| 3 years | 16.64 | 65.92 | |
| 5 years | 16.64 | 67.66 | |
| 10 years | 12.05 | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Feng Zhang
CEO | Chief Executive Officer | 79 | 29/02/1996 |
Zi Ping Luo
COO | Chief Operating Officer | 76 | 29/02/1996 |
William Peters
DFI | Director of Finance/CFO | 58 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Prins
BRD | Director/Board Member | 69 | 01/02/2003 |
William Peters
BRD | Director/Board Member | 58 | 04/08/2022 |
Diane Gerst
BRD | Director/Board Member | 66 | 01/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/9/26 | Sell | Chief Financial Officer | -4,139 | 0.0097% | ||
| 16/9/26 | Exercice | Chief Technology Officer | 30,000 | 0.0705% | ||
| 2/9/26 | Sell | Chief Technology Officer | -3,187 | 0.0075% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.59% | +8.99% | -0.63% | -43.59% | 1.17B | ||
| -0.01% | +1.69% | +63.50% | +117.58% | 1,056B | ||
| -1.61% | -0.71% | +48.89% | +70.56% | 655B | ||
| -1.12% | -0.45% | +19.35% | +72.93% | 471B | ||
| -1.72% | -4.25% | +37.79% | +39.89% | 342B | ||
| -0.40% | +4.12% | +22.89% | +29.04% | 277B | ||
| -0.51% | -1.05% | +12.98% | +12.92% | 257B | ||
| +1.32% | +7.75% | +55.19% | +56.43% | 226B | ||
| -0.61% | +0.48% | +34.95% | +100.58% | 189B | ||
| -0.24% | -3.21% | -27.79% | -61.37% | 170B | ||
| Average | -0.75% | +1.15% | +26.71% | +39.50% | 364.41B | |
| Weighted average by Cap. | -0.63% | +0.76% | +39.84% | +68.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 748M 660M 624M 565M 1.06B 71.76B 1.07B 7.47B 2.88B 36.65B 2.81B 2.75B 118B | 784M 692M 655M 593M 1.11B 75.28B 1.12B 7.84B 3.02B 38.44B 2.95B 2.88B 123B |
| Net income | 99.32M 87.6M 82.87M 75.1M 141M 9.53B 142M 992M 382M 4.87B 373M 365M 15.63B | 115M 102M 96.31M 87.27M 164M 11.08B 165M 1.15B 444M 5.66B 433M 424M 18.17B |
| Net Debt | 303M 268M 253M 229M 431M 29.12B 434M 3.03B 1.17B 14.87B 1.14B 1.11B 47.76B | 184M 162M 154M 139M 261M 17.67B 264M 1.84B 709M 9.02B 691M 676M 28.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | US$26.68 | -2.59% | 626,940 |
| 28/09/26 | US$27.39 | +4.82% | 751,801 |
| 25/09/26 | US$26.13 | -0.53% | 376,921 |
| 24/09/26 | US$26.27 | +5.25% | 572,080 |
| 23/09/26 | US$24.96 | +2.63% | 508,095 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMPH Stock
Select your edition
All financial news and data tailored to specific country editions

















